OVERVIEW

Oncology Briefings™: Harnessing the Predictive Powers of Biomarkers in Immuno-Oncology is organized by Physicians' Education Resource LLC (PER) and will be held from Jul 31, 2018 - Jul 31, 2019.

The target audience for this medical event is directed toward medical oncologists, oncology pathologists, clinical/biomedical researchers, hematologists, pathologists, and other healthcare professionals interested in personalized medicine and biomarker research. Nurse practitioners, nurses, physician assistants, pharmacists, fellows, and other healthcare professionals are also invited to participate. This CME Conference has been approved for a maximum of 1.0 Credit.

Description:
This activity, Oncology Briefings: Harnessing the Predictive Powers of Biomarkers in Immuno-Oncology, developed in Physicians’ Education Resource, LLC, (PER®) established Oncology Briefings legacy format, is an online interactive monograph that provides an overview of the current and future role of biomarkers in predicting pan-tumor response to immunotherapy in cancer. This presentation features a national thought leader, Hossein Borghaei, DO, MS, who provides key insights.

Educational Objectives:
Upon completion of this activity, participants should be better prepared to:
• Define next-generation sequencing (NGS) and comprehensive gene panels, and its utility in identifying potential biomarkers and response to cancer immunotherapeutics
• Explain the potential utility of NGS in characterizing the tumor microenvironment
• Synthesize and integrate clinical study data illustrating the appropriate use of NGS in immuno-oncology across multiple tumor types
• Identify current NGS technology platforms and comprehensive gene panels and their advantages and disadvantages